Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 25 Jan 2023 |
| Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger | 24 Jan 2023 |
| Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner | 12 Dec 2022 |
| Interim report for the first nine months of 2022 | 3 Nov 2022 |
| Company announcement | 7 Oct 2022 |